SG10201903822XA - Method for the enrichment of circulating tumor dna - Google Patents

Method for the enrichment of circulating tumor dna

Info

Publication number
SG10201903822XA
SG10201903822XA SG10201903822XA SG10201903822XA SG10201903822XA SG 10201903822X A SG10201903822X A SG 10201903822XA SG 10201903822X A SG10201903822X A SG 10201903822XA SG 10201903822X A SG10201903822X A SG 10201903822XA SG 10201903822X A SG10201903822X A SG 10201903822XA
Authority
SG
Singapore
Prior art keywords
circulating tumor
enrichment
tumor dna
relates
binding agents
Prior art date
Application number
SG10201903822XA
Other languages
English (en)
Inventor
Jacob Vincent Micallef
Marielle Herzog
Mark Edward Eccleston
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54427791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201903822X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1419225.6A external-priority patent/GB201419225D0/en
Priority claimed from GB201419299A external-priority patent/GB201419299D0/en
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Publication of SG10201903822XA publication Critical patent/SG10201903822XA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/622Ion mobility spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7023(Hyper)proliferation
    • G01N2800/7028Cancer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201903822XA 2014-10-29 2015-10-29 Method for the enrichment of circulating tumor dna SG10201903822XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1419225.6A GB201419225D0 (en) 2014-10-29 2014-10-29 Method for the enrichment of circulating tumor DNA
GB201419299A GB201419299D0 (en) 2014-10-30 2014-10-30 Method for the enrichment of circulating tumour DNA

Publications (1)

Publication Number Publication Date
SG10201903822XA true SG10201903822XA (en) 2019-05-30

Family

ID=54427791

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201903822XA SG10201903822XA (en) 2014-10-29 2015-10-29 Method for the enrichment of circulating tumor dna
SG11201702978VA SG11201702978VA (en) 2014-10-29 2015-10-29 Method for the enrichment of circulating tumor dna

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201702978VA SG11201702978VA (en) 2014-10-29 2015-10-29 Method for the enrichment of circulating tumor dna

Country Status (12)

Country Link
US (2) US20180024141A1 (https=)
EP (2) EP3809140A1 (https=)
JP (1) JP6721599B2 (https=)
CN (2) CN107209190B (https=)
AU (1) AU2015340378B2 (https=)
CA (1) CA2965752C (https=)
DK (1) DK3213084T4 (https=)
ES (1) ES2839973T3 (https=)
IL (1) IL251896A0 (https=)
PL (1) PL3213084T3 (https=)
SG (2) SG10201903822XA (https=)
WO (1) WO2016067029A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US11060145B2 (en) 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
EP3736344A1 (en) 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN106544341A (zh) * 2017-01-17 2017-03-29 上海亿康医学检验所有限公司 高效检测样本中的ctDNA的方法
WO2019053243A1 (en) 2017-09-18 2019-03-21 Santersus Sa METHOD AND DEVICE FOR PURIFYING BLOOD OF FREE CIRCULATING DNA
CN109932224A (zh) * 2017-12-18 2019-06-25 中国科学院大连化学物理研究所 一种富集提取循环肿瘤dna的方法
CN112119166B (zh) * 2018-03-13 2025-08-22 耶路撒冷希伯来大学伊萨姆研发有限公司 无细胞dna染色质免疫沉淀的诊断应用
CN112805563B (zh) * 2018-05-18 2025-06-13 约翰·霍普金斯大学 用于评估和/或治疗癌症的无细胞dna
GB201818963D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Methof for the detection of prostate cancer
GB201818965D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Method for the detection of colorectal cancer
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
GB201906201D0 (en) 2019-05-02 2019-06-19 Belgian Voltion Sprl Method for the detection of protate cancer
GB201906199D0 (en) 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
US12571051B2 (en) * 2019-08-27 2026-03-10 Belgian Volition Srl Method of isolating circulating nucleosomes
EP4041914A1 (en) * 2019-10-04 2022-08-17 Santersus AG Method for isolating and analyzing cell free dna
JP7349104B2 (ja) * 2019-11-13 2023-09-22 株式会社島津製作所 ベロ毒素の検出方法
IL293342B1 (en) 2019-12-02 2026-01-01 Belgian Volition Srl Using cell-free nucleosomes as biomarkers
WO2021236993A1 (en) * 2020-05-22 2021-11-25 Bloodq, Inc. Methods for characterizing cell-free nucleic acid fragments
GB202117799D0 (en) 2021-12-09 2022-01-26 Belgian Volition Srl Method for the detection of blood cancer
EP4453241A1 (en) * 2021-12-21 2024-10-30 Guardant Health, Inc. Methods and systems for combinatorial chromatin-ip sequencing
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
EP4490323A1 (en) 2022-03-11 2025-01-15 Belgian Volition SRL Differential diagnosis method
WO2024042210A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
EP4646208A1 (en) 2023-01-06 2025-11-12 Ideaya Biosciences, Inc. Treatment of er+ breast cancer comprising homologous recombination deficiency using parg inhibitor
WO2024223947A1 (en) 2023-04-28 2024-10-31 Belgian Volition Srl Use of cell free nucleosomes as biomarkers of carcinomas
GB202307768D0 (en) 2023-05-24 2023-07-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
GB202310137D0 (en) 2023-07-03 2023-08-16 Belgian Volition Srl Method for the detection of cancer
WO2025012440A1 (en) 2023-07-13 2025-01-16 Belgian Volition Srl Method for detection of the potential of a body fluid sample to produce extracellular traps
WO2025061853A1 (en) 2023-09-19 2025-03-27 Belgian Volition Srl Lateral flow test device
WO2025073909A1 (en) 2023-10-04 2025-04-10 Belgian Volition Srl Pcr method for detecting ctcf occupied cfdna fragments
WO2025093747A1 (en) 2023-11-02 2025-05-08 Belgian Volition Srl Novel rapid high-throughput method of netosis induction and inhibition with physiologically relevant molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
US20060115482A1 (en) * 2004-04-27 2006-06-01 The Regents Of The University Of California Modifications of histone proteins as indicators of cell proliferation and differentiation
WO2007121276A2 (en) * 2006-04-12 2007-10-25 Biocept, Inc. Enrichment of circulating fetal dna
EP2062912A1 (en) * 2007-11-26 2009-05-27 Koninklijke Philips Electronics N.V. Selective enrichment of post-translationally modified proteins and/or peptides
US20100240054A1 (en) * 2008-09-22 2010-09-23 Biocept, Inc. Identification and isolation of fetal cells and nucleic acid
WO2010120942A2 (en) * 2009-04-14 2010-10-21 The Regents Of The University Of California Histone modification patterns for clinical diagnosis and prognosis of cancer
WO2013010181A2 (en) * 2011-07-14 2013-01-17 University Of Massachusetts Methods of diagnosing cancer using epigenetic biomarkers
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2782928B1 (en) 2011-11-21 2017-01-04 The Royal Institution for the Advancement of Learning / McGill University Mutations of histone proteins associated with proliferative disorders
PT2788767T (pt) * 2011-12-07 2017-12-06 Belgian Volition Sprl Método de detecção de adutos de nucleosoma
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9388213B2 (en) * 2012-09-10 2016-07-12 The Rockefeller University Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

Also Published As

Publication number Publication date
US20220334128A1 (en) 2022-10-20
PL3213084T3 (pl) 2021-07-26
JP2017534300A (ja) 2017-11-24
US20180024141A1 (en) 2018-01-25
CN111505305B (zh) 2023-10-17
HK1243764A1 (en) 2018-07-20
CN111505305A (zh) 2020-08-07
IL251896A0 (en) 2017-06-29
EP3213084A1 (en) 2017-09-06
CA2965752C (en) 2024-04-02
CA2965752A1 (en) 2016-05-06
NZ731116A (en) 2024-03-22
EP3213084B2 (en) 2023-12-13
DK3213084T3 (da) 2021-01-18
WO2016067029A1 (en) 2016-05-06
ES2839973T3 (es) 2021-07-06
JP6721599B2 (ja) 2020-07-15
EP3213084B1 (en) 2020-11-25
CN107209190A (zh) 2017-09-26
EP3809140A1 (en) 2021-04-21
AU2015340378B2 (en) 2021-08-12
AU2015340378A1 (en) 2017-05-11
CN107209190B (zh) 2021-07-16
SG11201702978VA (en) 2017-05-30
DK3213084T4 (da) 2024-03-18

Similar Documents

Publication Publication Date Title
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
PH12017501967A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
EP3280822A4 (en) System and method for dna sequencing and blood chemistry analysis
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
MX2017015758A (es) Componente de dispositivo, dispositivo, y metodo para purificar y ensayar biomoleculas de muestras biologicas.
EP4438743A3 (en) Pancreatic cancer detection kit or device, and detection method
FI3901281T3 (fi) Biologisten näytteiden spatiaalisesti eroteltu moninkertainen nukleiinihappoanalyysi
HK1211260A1 (en) Method and kit for nucleic acid sequencing
IL267429A (en) Elite event ee-gm5 and methods and kits for detecting such an event in biological samples
EP3201350A4 (en) Method for nucleic acid analysis directly from an unpurified biological sample
SI4026917T1 (sl) Metoda in komplet za določanje smrti celic ali tkiva oz. izvora DNK tkiva ali celice z analizo metilacije DNK
HUE069742T2 (hu) Biológiai laboratóriumi rendszer és eljárás mûködtetésére
EP3149464A4 (en) System and method for electronic biological sample analysis
SG11201602686YA (en) Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species
EP3216852A4 (en) Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component
WO2011121454A3 (en) Direct nucleic acid analysis
MX2018015213A (es) Secuencia de acido nucleico para detectar la existencia del evento de soya transgenica dbn9004 en una muestra biologica, equipo que contiene la misma y metodo de deteccion para la misma.
GB201716883D0 (en) Method for determining the concentration of intact microorganisms in a sample
IL267433A (en) Elite event ee-gm4 and methods and kits for detecting such an event in biological samples
ZA201805983B (en) Method, system, reagent kit and system for verifying hd-hook effect sample
EP3202886A4 (en) Cultured algae water concentration system, method for operating cultured algae water concentration system, and method for concentrating algae water containing cultured algae
GB201616668D0 (en) Sequence data analyzer, DNA analysis system and sequence data analysis method
WO2016109799A3 (en) Method of rna isolation from clinical samples
EP3293270A4 (en) Reagent kit, apparatus, and method for detecting chromosome aneuploidy
SG11202108157WA (en) Biological analysis system and methods